Sanofi and Regeneron have received approval from the US Food and Drug Administration (FDA) for the use of Dupixent (dupilumab) as a treatment for patients with eosinophilic oesophagitis (EoE). The drug has been approved...

FDA Approves Lumryz for Narcolepsy The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release...

The NHS cost effectiveness body NICE has approved Gilead’s Yescarta for treatment of come adults with lymphoma. Gilead’s treatment will be funded through the Cancer Drugs Fund for adults with relapsed or refractory...

Shire announced that the Food and Drug Administration (FDA) has approved Motegrity (prucalopride) tablets for the treatment of adults with chronic idiopathic constipation (CIC).